PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The trial compares Laxabon® 4L versus Pursennid® Ex-Lax 36mg and 2L Laxabon® for large bowel cleansing prior to colonoscopy allocating patients planned for colonoscopy to one of the two cleansing regimens.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Umeå University
• Treatments: Cardiac Glycosides; Pharmaceutical Solutions; Senna Extract; Sennoside A&B; Sennosides

Criteria

Inclusion Criteria:

• Patient scheduled to undergo elective complete colonoscopy as an outpatient

• Age 18 or older

• The patient gives written informed consent and can understand the information given

• The patient can participate only once in the study

Exclusion Criteria:

• Earlier resection of the large bowel or rectum

• Active known colitis

• Ileus or gastro-intestinal obstruction